Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Net revenue $ 293,000 $ 171,000
Cost of sales 460,000 238,000
Gross loss (167,000) (67,000)
Operating expenses:    
Selling and administrative expenses 647,000 555,000
Research and development 290,000 336,000
Total operating expenses 937,000 891,000
Operating loss (1,104,000) (958,000)
Other income (expense):    
Change in fair value of derivative liabilities 11,000 0
Interest expense (42,000) (50,000)
Other expense (44,000)
Net loss $ (1,179,000) $ (1,008,000)
Net loss per share - basic and diluted (in dollars per share) $ (0.01) $ (0.01)
Weighted average number of common shares outstanding - basic and diluted (in shares) 230,863,490 114,537,944